Algorae Pharmaceuticals Passes All Nine Resolutions at 2026 Annual General Meeting

Aditi Sarkar

05 November 2026 03:14 PM AEDT

Algorae Pharmaceuticals Passes All Nine Resolutions at 2026 Annual General Meeting

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Algorae Pharmaceuticals (ASX:1AI) has disclosed that all nine resolutions put to shareholders at its Annual General Meeting held on 5 November 2026 were carried, including the approval of a 10% placement capacity, the election of two new directors, and the approval of performance rights for three named individuals.

Key Points

All nine resolutions were decided by poll and carried at the AGM held on 5 November 2026.
Resolution 2, approving a 10% placement capacity, was carried with 97.00% of poll votes in favour.
Mr David Gulland and Mr Troy Valentine were elected as directors, and Mr David Hainsworth was re-elected as a director.
Performance rights for Mr David Gulland, Mr Troy Valentine, and Mr David Hainsworth were each approved by poll.
The ratification of the appointment of auditor was carried with 97.46% of poll votes in favour.

Director Elections and Re-election Outcomes

The election of Mr David Gulland as a director was carried with 97.08% of poll votes in favour and 2.92% against. The election of Mr Troy Valentine as a director was carried with 96.88% of poll votes in favour and 3.12% against. The re-election of Mr David Hainsworth as a director was carried with 97.21% of poll votes in favour and 2.79% against. All three director resolutions were decided by poll in accordance with the Corporations Act 2001 and ASX Listing Rule 3.13.2.

Performance Rights Approvals for Named Individuals

Shareholders approved the issue of performance rights to each of Mr David Gulland, Mr Troy Valentine, and Mr David Hainsworth. The resolution approving performance rights for Mr Gulland was carried with 96.75% of poll votes in favour. The resolution for Mr Valentine was carried with 96.11% in favour, while the resolution for Mr Hainsworth was carried with 96.64% in favour. Each resolution was decided by poll, with abstentions recorded at 1,666,667, nil, and 20,000,000 votes respectively, as disclosed in the results summary.

Remuneration Report and Auditor Ratification

The adoption of the remuneration report, Resolution 1, was decided by poll and recorded 96.72% of votes in favour and 3.28% against, with 15,000 votes abstaining. The filing noted this resolution outcome without disclosing a formal "carried" designation in the results column, consistent with the advisory nature of a remuneration report vote. The ratification of the auditor appointment, Resolution 6, was carried with 97.46% of poll votes in favour, the highest approval rate across all resolutions put to shareholders at the meeting. The 10% placement capacity resolution was carried with 97.00% in favour.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.